- Report
- April 2023
- 275 Pages
Global
From €3832EUR$3,990USD£3,299GBP
- Report
- September 2022
- 104 Pages
Asia Pacific
From €1441EUR$1,500USD£1,240GBP
- Report
- April 2020
- 49 Pages
Global
From €3837EUR$3,995USD£3,303GBP
- Report
- March 2022
- 180 Pages
Global
From €3319EUR$3,456USD£2,858GBP
- Report
- November 2021
- 145 Pages
Global
From €3565EUR$3,712USD£3,069GBP
- Book
- September 2022
- 480 Pages
- Book
- December 2019
- 432 Pages
- Book
- December 2019
- 432 Pages
- Book
- August 2019
- 264 Pages
- Book
- February 2016
- 448 Pages
- Book
- February 2010
- 260 Pages
- Book
- November 2019
China
- Book
- October 2020
Asia Pacific
The Chest Pain market within the context of Cardiology is a highly specialized field of medicine that focuses on diagnosing and treating chest pain and other related conditions. It is a complex area of medicine that requires a thorough understanding of the anatomy and physiology of the chest, as well as the ability to interpret and analyze diagnostic tests. Chest pain can be caused by a variety of conditions, including coronary artery disease, pulmonary embolism, and aortic dissection. Treatment options vary depending on the underlying cause of the chest pain, and may include medications, lifestyle changes, and/or surgery.
The Chest Pain market is a rapidly growing field, with new technologies and treatments being developed to improve diagnosis and treatment. Companies in this market include Abbott, Boston Scientific, Medtronic, St. Jude Medical, and Philips Healthcare. Show Less Read more